Yahoo
NasdaqCM - Nasdaq Real Time Price USD

INVO Fertility, Inc. (IVF)

1.0600 -0.0900 (-7.83%)
At close: August 21 at 4:00:01 PM EDT
1.0600 0.0000 (0.00%)
After hours: August 21 at 7:59:46 PM EDT
Chart Range Bar
Loading chart for IVF
  • Previous Close 1.1500
  • Open 1.1200
  • Bid 0.7992 x 200
  • Ask 1.3900 x 200
  • Day's Range 1.0600 - 1.1200
  • 52 Week Range 0.9000 - 84.4000
  • Volume 384,060
  • Avg. Volume 4,454,308
  • Market Cap (intraday) 2.657M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 340.3200
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 20.00

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

www.invofertility.com

40

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 8/21/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IVF
71.85%
S&P 500 (^GSPC)
12.11%

1-Year Return

IVF
97.48%
S&P 500 (^GSPC)
20.47%

3-Year Return

IVF
99.95%
S&P 500 (^GSPC)
74.43%

5-Year Return

IVF
100.00%
S&P 500 (^GSPC)
72.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 2.02M
Earnings -5.54M
Profit Margin -274.88%

Q3

FY25

Q4

FY25

Q1

FY26

-4M
-2M
0
2M
-200.0%
-100.0%
0.0%
100.0%

Analyst Insights

View More

Analyst Price Targets

20.00
20.00 Average
1.0600 Current
20.00 High

Statistics

View More

Valuation Measures

Annual
As of 8/20/2026
  • Market Cap

    2.68M

  • Enterprise Value

    3.27M

  • Trailing P/E

    0.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.16

  • Price/Book (mrq)

    0.16

  • Enterprise Value/Revenue

    0.42

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -70.18%

  • Return on Assets (ttm)

    -16.41%

  • Return on Equity (ttm)

    -55.28%

  • Revenue (ttm)

    7.53M

  • Net Income Avi to Common (ttm)

    -7.09M

  • Diluted EPS (ttm)

    340.3200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.73M

  • Total Debt/Equity (mrq)

    23.78%

  • Levered Free Cash Flow (ttm)

    -4.82M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.0600 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: